SUNAMACHI-ELEMENTARY
14.12.2020 15:32:18 CET | Business Wire | Press release
The Floating City, a virtual island created within the popular Nintendo Switch game Animal Crossing: New Horizons (ACNH) , is providing elementary schools with a platform for special lessons on the theme of SDGs. Led by the 6th Sunamachi Elementary School in Koto-ku, Tokyo, the initiative kicked off on December 10 with a special open class titled “Special Lessons in ACNH .” Participating children visited The Floating City for an opportunity to learn about environmental issues via the game.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201214005513/en/
The Floating City is a virtual floating island launched within ACNH on December 8, 2020, with supervision from one co-founder of Blue Frontiers, a sustainable property developer currently working toward the creation of a real-world sustainable floating island in the Southern Hemisphere. The in-game island’s content is designed to boost interest in environmental issues among the younger generation, leveraging gameplay to encourage them to think about the future.
Special Lessons in ACNH at Koto-ku 6th Sunamachi Elementary School, Grade 5
The special open class saw participation from 30 children at Tokyo’s 6th Sunamachi Elementary School. The Floating City within ACNH is home to numerous animals, including some endangered species, and the virtual island also incorporates various activities for fun, guided learning.
Children actively asked questions in the session, which focused on current global environmental issues and was led by fisheries scientist Dr. Hiroaki Chiba, an associate professor at Kitasato University. After the lesson, Dr. Chiba commented, “Learning about the environment through games is a great educational tool which creates an opportunity to think about environmental issues and the future.”
The Floating City lets children experience environmental issues through ACNH
In the special lesson, children experienced The Floating City within ACNH through gameplay, deepening their understanding of environmental issues while visiting the island’s various virtual facilities. They learned about sustainable living on The Floating City, which echoes a real floating island, with a wind farm to create electricity through the power of nature and a restaurant serving dishes prepared only from ingredients grown on the island. The game also provides enjoyable opportunities to experience environmental issues, such as visiting a museum of endangered animals and talking with an African elephant. Children were excited by the fishing and bug-catching activities, and enthralled by the island’s many unique features.
Lesson topics: Global environmental issues and the future of fish
Dr. Hiroaki Chiba joined as a special guest instructor and delivered a lesson on what can be done to resolve current environmental issues and marine pollution. Beginning with an explanation of the serious environmental impacts of rising carbon dioxide levels, he described how Japan’s abundant ocean ecosystem has been disrupted by global warming and the acidification of seawater caused by this greenhouse gas, as well as by overfishing.
Dr. Chiba also raised the pressing issue of ocean plastic pollution, pointing out that the cumulative amount of plastic waste in the world is predicted to exceed 12 billion tons by 2050. These plastics are the source of countless “microplastic” particles that cannot be broken down by waves or ultraviolet rays, and even hold the potential to turn oceans into a plastic “soup” uninhabitable to fish. When asked by the children about fish populations around the world, Dr. Chiba explained that fish numbers are decreasing worldwide due to shrinking habitats for cold-water fish caused by global warming and rising sea temperatures.
Finally, students studied the adverse impacts of environmental damage on humans. They learned what they can do to be more eco-friendly and help prevent marine pollution, including practicing the three R’s (reduce, reuse, recycle) and purchasing ecolabelled products.
About The Floating City and Blue Frontiers
Floating cities are a pioneering sustainability solution whose potential to combat various environmental issues has even seen them discussed by a UN-Habitat roundtable. The rich natural surroundings of this in-game recreation have numerous features designed to help users enjoy learning about sustainability and environmental issues––from the many animals representing endangered species who welcome visitors to the island, to fishing and bug-catching activities that generate a warning when users catch more than they need. The Floating City’s guided learning opportunities even include a museum dedicated to extinct animals and a restaurant with a menu that spotlights disappearing ingredients.
The Floating City was created under the supervision of one co-founder of Blue Frontiers, a company that aims to build an environmentally friendly, sustainable floating island in the near future. Visit https://www.blue-frontiers.com/en/ for more information.
Applying for a special lesson
The Floating City is accepting applications from elementary schools interested in hosting special lessons as described above. If your school would like to participate, please email contact@the-floatingcity.com .
Visiting The Floating City
Lie down in your own in-game bed and enter the Dream Address code (DA-8310-5913-5018) to pay a visit to the island.
What you need to visit The Floating City for an in-game guided tour:
- Nintendo Switch on which to play Animal Crossing: New Horizons
- In-game airport access
- Nintendo Switch Online subscription
- Communicative competence in English or Japanese
What you need to visit The Floating City for a non-guided trip:
- Nintendo Switch on which to play Animal Crossing: New Horizons
- Access to in-game dreaming feature
- Nintendo Switch Online subscription
View source version on businesswire.com: https://www.businesswire.com/news/home/20201214005513/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
Pivotal Trial Data for EP0031 (A400), a Next-Generation Selective RET Inhibitor (SRI), in RET Positive Advanced NSCLC, to be Presented at ASCO 202622.5.2026 11:18:00 CEST | Press release
Ellipses Pharma (“Ellipses”), a global oncology drug development company with a pipeline of innovative programmes, announced today that its partner, Kelun-Biotech, is presenting pivotal trial data for EP0031/A400, for the potential treatment of RET-fusion positive Non-Small Cell Lung Cancer (NSCLC), at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting Chicago, May 29 to June 2. Efficacy and safety of lunbotinib (A400/EP0031), a next-generation selective RET inhibitor (SRI), from a pivotal phase Ⅱ study in patients with advanced RET-fusion positive non-small cell lung cancer (NSCLC), will be presented as an oral presentation scheduled on May 29, 2026, 14:36-14:48 local time (Abstract #8505: Lung Cancer – Non-Small Cell Metastatic). The oral presentation of these data at the prestigious ASCO annual meeting, represents another major milestone in the global development of EP0031/A400 as a next generation SRI. The data were generated in Kelun-Biotech’s Phase 2 study (NCT0
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
